To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES) (HERMES)
Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Prostatic Cancer
About this trial
This is an interventional treatment trial for Lower Urinary Tract Symptoms focused on measuring Temporary prostatic stent, Indwelling catheter, Cryotherapy, Prostate cancer, Benign prostatic hyperplasia, Rezum, EchoLaser
Eligibility Criteria
Inclusion Criteria: Willing and able to provide written informed consent prior to enrollment (if applicable). Subjects must meet all inclusion criteria to be eligible for study enrollment. Men between 18 and 85 years old. Undergo focal therapy for prostate cancer, water vapour energy ablation Rezum® or EchoLaser®. Willing to be seen by the investigator and answer questions and fill out questionnaires up to a month after surgery. Exclusion Criteria: Urethral stricture <22F. Gross haematuria Prostate volume > 80cc Prostate craniocaudal length > 6cm Patients with long-term urinary catheters or other urinary drainage systems Lack of commitment on the part of the patient to attend the follow-up as required.
Sites / Locations
- Juan Ignacio Martinez-Salamanca
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Temporary prostatic stent (Exime®)
Indwelling catheter
Post-operative placement of temporary prostatic stent (EXIME)
Post-operative placement of indwelling catheter